169 related articles for article (PubMed ID: 11883294)
1. [Serum cytokines in patients with ovarian cancer and benign ovarian cysts].
Nowak M; Szpakowski M; Malinowski A; Wieczorek A; Maciołek-Blewniewska G; Wilczyński JR; Szpakowski A; Wierzbicka E; Małafiej E; Oszukowski P
Ginekol Pol; 2001 Dec; 72(12A):1444-8. PubMed ID: 11883294
[TBL] [Abstract][Full Text] [Related]
2. [Maternal serum cytokines in labor, pregnancy and chorioamnionitis].
Nowak M; Oszukowski P; Jaczewski B; Małafiej E; Wierzbicka E; Czichos E; Wilczyński JR; Szpakowski M
Ginekol Pol; 2001 Dec; 72(12):1158-62. PubMed ID: 11883229
[TBL] [Abstract][Full Text] [Related]
3. Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours.
Daraï E; Detchev R; Hugol D; Quang NT
Hum Reprod; 2003 Aug; 18(8):1681-5. PubMed ID: 12871882
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors.
Nowak M; Glowacka E; Szpakowski M; Szyllo K; Malinowski A; Kulig A; Tchorzewski H; Wilczynski J
Neuro Endocrinol Lett; 2010; 31(3):375-83. PubMed ID: 20588232
[TBL] [Abstract][Full Text] [Related]
5. [Significantly increased interleukin-1A and interleukin-1 soluble type II receptor levels in women with ovarian cancer].
Kondera-Anasz Z; Mielczarek-Palacz A; Switała J
Ginekol Pol; 2003 Sep; 74(9):761-6. PubMed ID: 14674121
[TBL] [Abstract][Full Text] [Related]
6. Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies.
Sipak-Szmigiel O; Włodarski P; Ronin-Walknowska E; Niedzielski A; Karakiewicz B; Słuczanowska-Głąbowska S; Laszczyńska M; Malinowski W
J Ovarian Res; 2017 Apr; 10(1):25. PubMed ID: 28376925
[TBL] [Abstract][Full Text] [Related]
7. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.
Robak E; Sysa-Jedrzejewska A; Dziankowska B; Torzecka D; Chojnowski K; Robak T
Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317
[TBL] [Abstract][Full Text] [Related]
8. Role of Intracystic Cytokines and Nitric Oxide in Ovarian Neoplasms.
Martins-Filho A; Jammal MP; Micheli DC; Tavares-Murta BM; Etchebehere RM; Murta EFC; Nomelini RS
Scand J Immunol; 2017 Dec; 86(6):462-470. PubMed ID: 28960399
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum interleukin-6, interleukin-8, tumor necrosis factor-alpha and interferon-gamma in preterm labor.
Bahar AM; Ghalib HW; Moosa RA; Zaki ZM; Thomas C; Nabri OA
Acta Obstet Gynecol Scand; 2003 Jun; 82(6):543-9. PubMed ID: 12780425
[TBL] [Abstract][Full Text] [Related]
10. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.
Moradi MM; Carson LF; Weinberg B; Haney AF; Twiggs LB; Ramakrishnan S
Cancer; 1993 Oct; 72(8):2433-40. PubMed ID: 8402460
[TBL] [Abstract][Full Text] [Related]
11. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
Sánchez-Zauco N; Torres J; Gómez A; Camorlinga-Ponce M; Muñoz-Pérez L; Herrera-Goepfert R; Medrano-Guzmán R; Giono-Cerezo S; Maldonado-Bernal C
BMC Cancer; 2017 May; 17(1):384. PubMed ID: 28558708
[TBL] [Abstract][Full Text] [Related]
12. Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer.
Sanguinete MMM; Oliveira PH; Martins-Filho A; Micheli DC; Tavares-Murta BM; Murta EFC; Nomelini RS
Immunol Invest; 2017 Oct; 46(7):677-688. PubMed ID: 28872976
[TBL] [Abstract][Full Text] [Related]
13. Serum cytokines as biomarkers for nonsurgical prediction of endometriosis.
Othman Eel-D; Hornung D; Salem HT; Khalifa EA; El-Metwally TH; Al-Hendy A
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):240-6. PubMed ID: 17582674
[TBL] [Abstract][Full Text] [Related]
14. Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.
Kooi S; Freedman RS; Rodriguez-Villanueva J; Platsoucas CD
Lymphokine Cytokine Res; 1993 Dec; 12(6):429-37. PubMed ID: 8123759
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity.
Jacob SE; Nassiri M; Kerdel FA; Vincek V
Mediators Inflamm; 2003 Oct; 12(5):309-13. PubMed ID: 14760939
[TBL] [Abstract][Full Text] [Related]
16. [Selected cytokines (Il-6, Il-8, Il-10, MCP-1, TNF-alpha) in children and adolescents with atherosclerosis risk factors: obesity, hypertension, diabetes].
Głowińska B; Urban M
Wiad Lek; 2003; 56(3-4):109-16. PubMed ID: 12923954
[TBL] [Abstract][Full Text] [Related]
17. Serum cytokines and CXCR2: potential tumour markers in ovarian neoplasms.
Micheli DC; Jammal MP; Martins-Filho A; Côrtes JRXM; Souza CN; Nomelini RS; Murta EFC; Tavares-Murta BM
Biomarkers; 2020 Sep; 25(6):474-482. PubMed ID: 32544350
[TBL] [Abstract][Full Text] [Related]
18. Does vitamin D mediate inhibition of epithelial ovarian cancer by modulating cytokines?
Mohapatra S; Saxena A; Gandhi G; Koner BC; Singh T; Ray PC
Clin Transl Oncol; 2015 Aug; 17(8):590-5. PubMed ID: 25740667
[TBL] [Abstract][Full Text] [Related]
19. Clinical importance of determination of cytokines in patients with ovary tumours.
Abdullaeva LM
Lik Sprava; 2010; (3-4):56-9. PubMed ID: 21261134
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic and prognostic significance of serum levels of cytokines in patients with advanced serous ovarian cancer prior to surgery].
Zhu X; Ying LS; Xu SH; Zhu CH; Xie JB
Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):666-70. PubMed ID: 21176531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
